INS and stroke disorder: Notably, the continuous insulin infusion therapy (CIIT) group showed no cases of in-hospital mortality, postoperative stroke, myocardial infarction, multiple organ failure, gastrointestinal bleeding, or need for extracorporeal hemocorrection (Figure 6).